3 February 2021
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals for $7.2 Billion
The acquisition will create a leader in neuroscience, expanding product diversification and combining expertise in sleep, oncology, and epilepsy, with a robust pipeline and strong financial growth potential.
